跳至主要内容
临床试验/NCT06264466
NCT06264466Unknown不适用

Safety and Efficacy of the Novel Speedboat UltraSlim With Radiofrequency and Microwave Ablation Flexible Biplolar for Per-Oral Endoscopic Myotomy in Patients With Achalasia: A Single Center Prospective Study

Instituto Ecuatoriano de Enfermedades Digestivas2 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
73
试验地点
2
主要终点
Technical success of procedure

研究概览

简要总结

Per-oral endoscopic myotomy (POEM) is a minimally invasive therapy for achalasia. The procedure has demonstrated high technical and clinical success with lower adverse events. Different types of knives have been used for cutting and coagulation during the procedure; however, exchanging accessories is sometimes needed to perform all the stages of POEM.

To overcome this disadvantage, the investigators aim to evaluate a single device that integrates in its tip bipolar radiofrequency and microwave, the Speedboat Ultraslim (Creo Medical, UK) for cutting and coagulation during POEM procedure. Some of the promise's advantages derived from its use are: (1) less inflammation, (2) clear differentiation between layers, (3) the use of a single device for the procedure.

This single-center, prospective, interventional study will include patients with achalasia submitted to POEM procedure, with or without fundoplication (POEM-F). All stages (mucosal incision, submucosal tunneling, myotomy) of POEM will be performed using the Speedboat ultraslim flexible catheter. Technical and clinical success, along with safety will be the primary endpoints; while, post-procedure reflux symptoms and quality of life will be assessed as secondary outcomes with reflux severity index (RSI) and the Northwestern Esophageal Quality of Life (NEQOL), respectively.

详细描述

Achalasia is characterized by the absence of esophageal peristalsis and the inability of the lower esophageal sphincter (LES) to relax. To date, the therapies with higher success rates are the Heller myotomy and the minimally invasive per-oral endoscopic myotomy (POEM). Different tools have been developed for the different POEM stages (mucosal incision, submucosal tunneling, myotomy, and closure). However, some devices need exchanging accessories for cutting and coagulation.

In light of the above, the investigators aim to evaluate a newly launched ultra-slim flexible catheter, Speedboat Ultraslim (Creo Medical, UK) that integrates bipolar radiofrequency (RFA) energy and microwave in its tip for cutting and coagulation, respectively, in patients with achalasia. Some proposed advantages of using this device during POEM are (1) less inflammation and better healing process derived from localized bipolar energy; (2) a protective full that facilities clear differentiation between muscular and mucosal layers; (3) the use of a single device to complete the POEM procedure.

After completing the inclusion criteria, the patients with achalasia will undergo POEM (anterior or posterior incision) with or without fundoplication (F-POEM). The procedures will be performed by previously trained expert endoscopist. The mucosal incision, submucosal tunneling and cutting will be performed using RFA energy, while coagulation will be performed with microwave, both integrated in the tip of the Ultraslim Speedboat.

Technical and clinical success along with safety will be the primary outcomes; while post-procedure reflux symptoms and quality of life will be assessed as secondary outcomes with reflux severity index (RSI) along with endoscopic and pH studies; and the Northwestern Esophageal Quality of Life (NEQOL), respectively.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with 18 years of age or older.
  • Patients referred to the participating center (IECED) with a clinical diagnosis of achalasia with an indication for POEM, including previously failed Heller myotomy, balloon dilation or POEM
  • Patients who provide informed consent.

排除标准

  • Patients who have contraindications for esophagogastroduodenoscopy (EGD).
  • Patients with an Eckardt score < 3 before POEM.
  • Positive diagnosis of Chagas disease.
  • Patients unable to withstand general anesthesia.
  • Pregnancy and lactation.
  • Barret's esophagus.

结局指标

主要结局

Technical success of procedure

时间窗: up tp four hours

Successful competition of all the stages of the POEM procedure with passage of endoscope through the EGJ.

Clinical success of procedure

时间窗: up to one year

The clinical success of the POEM procedure will be assessed by using the Eckardt score. An Eckardt score of ≤3 will be considered as clinical success.

Frequency of adverse events attributable to the procedure

时间窗: Up to three months

Frequency of adverse events attributable to the procedure, based on American Society of Gastrointestinal Endoscopy (ASGE) lexicon.

次要结局

  • Assessment of Gastroesophageal reflux disease severity(Up to one year)
  • Rate of Gastroesophageal reflux disease(Up to one year)
  • Change in health-related quality of life after POEM(Up to six months)

研究者

发起方
Instituto Ecuatoriano de Enfermedades Digestivas
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Safety and Efficacy of a Novel Flexible Bipolar in... | 临床试验